In 2015, the Federal Office for Public Health (FOPH) launched an HTA program intending to reassess the benefits already reimbursed by compulsory health insurance. This program examines potentially obsolete benefits to remove them from the benefit catalog or to limit the obligation to reimburse.
The program is organized HTA section of the FOPH with the following list of ongoing procedures:
- Multigene Expression Tests in Breast Cancer (link);
- Thyroid hormone tests to confirm primary hypo- or hyperthyroidism (link);
- Vitamin D testing (link);
- Cardiac catheterization for coronary artery disease (link);
- Rapid tests in physician’s office (link);
- Invasive procedures for coronary artery disease (link);
- Folic acid tests for suspected folic acid deficiency (link).
The final reports will be published on the FOPH website upon completion.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.